Tracking the activity of billionaire hedge fund managers is a great way to identify profitable investments that will help you beat the market.
Keep Reading →
March 10 - Hedge Funds, News
Roberto Mignone's Bridger Management is a fund with around $2.0 billion in assets, one that is focused on healthcare stocks, which represent nearly one-half of the fund's equity...
Keep Reading →
March 3 - Hedge Funds, News
Billionaire George Soros’ Soros Fund Management has recently filed a Form 13F with the U.S.
Keep Reading →
February 19 - Hedge Funds, News
As the 13F season carries on, we continue to track the top hedge funds’ filings.
Keep Reading →
August 14 - Hedge Funds, News
North Tide Capital financial investment advisory firm headquartered in Boston, Massachusetts, founded and managed by Conan Laughlin. Before this, Mr.
Keep Reading →
June 4 - Hedge Funds, News
For the last several years, nobody has been more outspokenly bearish on Japan than Kyle Bass.
Keep Reading →
May 26 - Hedge Funds
Boston-based North Tide Capital was founded by Conan Laughlin in 2011. The fund focuses on the healthcare industry and has an estimated about $850 million in assets.
Keep Reading →
March 28 - Hedge Funds, News
Owl Creek Asset Management was founded in 2001 in New York by Jeffrey Altman, its current manager.
Keep Reading →
March 5 - Hedge Funds, News
Stan Druckenmiller is a billionaire, and was the long-time manager of Duquesne Capital. Now, he oversees a family office, but his investing strategy is mostly the same.
Keep Reading →
February 24 - Hedge Funds, News
In the current round of 13F filings, hedge funds and other institutional investors are disclosing their equity portfolios as held at the end of the last year.
Keep Reading →
February 18 - Hedge Funds, News
In the current round of 13F filings, hedge funds and other institutional investors are disclosing their equity portfolios as held at the end of the last year.
Keep Reading →
February 7 - Hedge Funds, News
Of all of the many sound investing principles that legendary teacher and investor Ben Graham put forward, he believed that his concept of “margin of safety” was the most important...
Keep Reading →
September 19 - News
Big Pharma gets plenty of hype.
Keep Reading →
September 17 - News
GlaxoSmithKline plc (ADR) (NYSE:GSK) and its partner Theravance Inc (NASDAQ:THRX) recently scored a second victory in their quest to treat chronic obstructive pulmonary disease...
Keep Reading →
September 16 - News
There are plenty of biotech companies that put all of their eggs in one basket these days.
Keep Reading →
September 16 - News
After the market closed on July 30, antibiotic expert Cubist Pharmaceuticals Inc (NASDAQ:CBST) announced two acquisitions worth up to a combined $1.6 billion.
Keep Reading →
September 15 - News
A couple months may not seem like a long time, but when you're diagnosed with pancreatic cancer, the prospect of a few months makes a huge difference.
Keep Reading →
September 13 - Dividend Stocks, News
In a couple of years, Amgen, Inc. (NASDAQ:AMGN) will have to face the music when the patent for its $4 billion a year drug, Neulasta, expires in the U.S. and Europe.
Keep Reading →
September 12 - News
When most biotech investors think of cancer treatments, they tend to think of large established players like Roche and Amgen.
Keep Reading →
September 12 - News
A couple of recent events got me thinking about price elasticity and how a savvy investor can capitalize on producers of inelastic products.
Keep Reading →
September 10 - News
Since the time covered in last week's update, Microsoft Corporation (NASDAQ:MSFT) lost more in market value for the real-money Inflation-Protected Income Growth portfolio ...
Keep Reading →
September 10 - News
In the 21st century investor’s toolkit, there are a multitude of metrics investors can use to track Mr. Market.
Keep Reading →
September 5 - News
This past week has been fairly brutal to stocks as the situation in Syria deteriorated and American saber-rattling suggested that a military intervention may be right around the...
Keep Reading →
September 4 - News
Allergan, Inc. (NYSE:AGN), the diversified health care giant best known for Botox, boasts an impressive portfolio of products.
Keep Reading →
August 30 - News
Shares of Perrigo Company (NYSE:PRGO), one of the world's largest health care suppliers, slid with the broader market on Aug.
Keep Reading →
August 27 - News
After a second offer, Amgen, Inc. (NASDAQ:AMGN) and Onyx Pharmaceuticals, Inc.
Keep Reading →
August 27 - News
Dividend investors would be wise to focus not just on a stock's current yield, but also on the long-term growth potential of its dividends.
Keep Reading →
August 27 - Dividend Stocks, News
The wild swings in the market continued this past week, aided and abetted by both Goldman Sachs' trading glitch and the unexpected mid-session Nasdaq shutdown.
Keep Reading →
August 27 - News
Judging by the numbers, Galena Biopharma Inc (NASDAQ:GALE) isn't exactly a stock many would call great.
Keep Reading →
August 26 - News
A finale has at last arrived for the biotech drama of summer 2013. Amgen, Inc. (NASDAQ:AMGN) announced yesterday that it will buy Onyx Pharmaceuticals, Inc.
Keep Reading →
August 26 - News
In the eyes of many of your fellow readers, hedge funds are seen as useless, old financial vehicles of an era lost to time.
Keep Reading →
August 26 - News
Breast cancer claims more than 40,000 lives in the United States annually and is one of the leading causes of death for females globally.
Keep Reading →
August 23 - News
Like most pharma companies, Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA)'s stock price generally trades akin to the actions of a roller coaster.
Keep Reading →
August 22 - News
Bernard Horn, the manager of Polaris Capital Management, is a former employee of MDT Advisers.
Keep Reading →
August 19 - Hedge Funds
It's a disease that doesn't often find itself in the spotlight, but multiple sclerosis is quickly becoming an ailment that drugmakers are focusing their efforts on to make a quality...
Keep Reading →
August 19 - News
Sometimes the market drops, as do even the greatest companies within it.
Keep Reading →
August 13 - News
Pharmaceutical companies are always looking for competitive advantages.
Keep Reading →
August 13 - News
Will generic pharmaceutical makers like Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) and Perrigo Company (NYSE:PRGO) continue to be a value play after Obamacare kicks...
Keep Reading →
August 12 - News
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has been stuck is share purgatory for a number of years.
Keep Reading →
August 6 - News
Maybe Texas just needs to fire up Ol' Sparky again.
Keep Reading →
August 5 - News
The investing waters can get pretty choppy from time to time with a developmental stage company. A look at the five-year chart of Momenta Pharmaceuticals, Inc.
Keep Reading →
August 2 - News
Hidden beneath all the numbers and metrics in Biogen Idec Inc (NASDAQ:BIIB)'s recent earnings report is a key confirmation of a shifting market in the treatment of multiple sclerosis...
Keep Reading →
August 1 - News
Taro Pharmaceutical Industries Ltd. (NYSE:TARO) hardly gets the attention it deserves.
Keep Reading →
August 1 - News
With the SPDR S&P Biotech Index up 29% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Keep Reading →
July 29 - News
The United States Court of Appeals is making this one miserable summer for Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA).
Keep Reading →
July 29 - News
The recent rally in shares of Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) may suggest investors are regaining some confidence in this pharmaceutical manufacturer.
Keep Reading →
July 23 - News
The medical community certainly spends a lot of time and money researching treatments for cardiovascular disease and cancer.
Keep Reading →
July 15 - News
The real-money Inflation-Protected Income Growth portfolio just finished an astonishingly strong week, rising by more than $1,080 since the prior week's update to close with a...
Keep Reading →
July 15 - News
VIVUS, Inc. (NASDAQ:VVUS) has found an Italian to help it out.
Keep Reading →
July 10 - News
Investors love stocks that consistently beat the Street without getting ahead of their fundamentals and risking a meltdown.
Keep Reading →
July 10 - News
